AMPK, a central sensor of cellular energy, is a eukaryotic heterotrimeric serine/threonine kinase, and it has emerged as a therapeutic target for metabolic disorders including obesity. This evidence concerns the gene MARK2 and obesity due to melanocortin 4 receptor deficiency.